Screening for type 2 diabetes--where are we now?
Lancet
.
2010 Apr 17;375(9723):1324-6.
doi: 10.1016/S0140-6736(10)60455-2.
Epub 2010 Mar 29.
Author
Guy Rutten
1
Affiliation
1
University Medical Center Utrecht, Julius Center for Health Sciences and Primary Care, Utrecht, Netherlands. g.e.h.m.rutten@umcutrecht.nl
PMID:
20356620
DOI:
10.1016/S0140-6736(10)60455-2
No abstract available
Publication types
Comment
MeSH terms
Adult
Cost-Benefit Analysis
Diabetes Mellitus, Type 2 / diagnosis*
Diabetes Mellitus, Type 2 / economics
Humans
Middle Aged
Models, Biological
Risk Factors
United Kingdom
United States